Veradigm | Fremdkapital

Aktienkurs
4.30
Täglich Wechseln
-0.20 -4.44%
Monatlich
-9.47%
Jährlich
-19.63%
Q1 Prognose
7.75




Fremdkapital Veränderung Datum
Alcidion AUD 694K 17K 2025-06
Ambu A/S DKK 14M 448M 2025-12
Amplifon EUR 1.11B 304.77M 2025-09
Cardinal Health USD 8.35B 633M 2025-12
Centene USD 17.35B 194M 2025-12
Charles River Laboratories USD 2.19B 146.92M 2025-09
Cigna USD 30.95B 4.47B 2025-09
Convatec Group USD 1.18B 211.4M 2024-12
CVS Health USD 60.5B 6M 2025-12
Diasorin EUR 472.05M 199.95M 2025-06
Elevance Health USD 30.8B 376M 2025-12
General Electric Aerospace USD 18.81B 37M 2025-12
Gulf Medical Proj AED 4.42M 0 2025-03
Humana USD 12.37B 238M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 3.9M 2025-09
Maximus USD 1.51B 227.61M 2025-12
McKesson USD 5.43B 586M 2025-12
Med Life RON 1.42B 49.61M 2025-06
Molina Healthcare USD 3.95B 98M 2025-12
Omnicell USD 167.6M 302K 2025-12
Oriola-kd EUR 38.9M 600K 2025-09
Owens Minor USD 1.9B 89.47M 2025-03
Quest Diagnostics USD 5.17B 4M 2025-12
Rede D'or Sao Luiz BRL 44.93B 9.86B 2025-09
Siemens Healthineers EUR 9.85B 1.49B 2025-12
Sonova Holding CHF 1.39B 209.8M 2025-06
Supermax Corporation Bhd MYR 17.61M 3.97M 2025-09
UnitedHealth USD 72.32B 79M 2025-12
Veradigm USD 200.33M 431K 2022-09
Xerox USD 3.48B 785M 2025-06


Veradigm Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.